Peripheral blood progenitor cell transplantation as an alternative to autologous marrow transplantation in the treatment of acute myeloid leukemia. 1997

B Löwenberg, and W L van Putten, and A Ferrant, and G Ossenkoppele, and E Vellenga, and L F Verdonck, and A Gratwohl, and M A Boogaerts
Dr. Daniel den Hoed Cancer Center, Erasmus University, Rotterdam, The Netherlands.

Herein we report on the feasibility of mobilizing peripheral blood progenitor cells (PBPC) in a prospective study of the HOVON-SAKK Groups in 96 cases with newly diagnosed acute myeloid leukemia (AML). Among 96 patients, 76 patients (79%) entered complete remission. Mobilization was undertaken with variable dosages of G-CSF in 63 patients, and 54 patients (87%) were leukapheresed. The comparative yields of pheresis following the G-CSF schedules and hematopoietic recovery data are presented and discussed. PBPC transplantation results in faster hematopoietic regeneration compared to autologous marrow grafting in the prior AML HOVON study.

UI MeSH Term Description Entries
D007937 Leukapheresis The preparation of leukocyte concentrates with the return of red cells and leukocyte-poor plasma to the donor. Leukocytapheresis,Leukopheresis,Lymphapheresis,Lymphocytapheresis,Leukocytopheresis,Lymphocytopheresis,Lymphopheresis,Leukaphereses,Leukocytaphereses,Leukocytophereses,Leukophereses,Lymphaphereses,Lymphocytaphereses,Lymphocytophereses,Lymphophereses
D007951 Leukemia, Myeloid Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites. Granulocytic Leukemia,Leukemia, Granulocytic,Leukemia, Myelocytic,Leukemia, Myelogenous,Myelocytic Leukemia,Myelogenous Leukemia,Myeloid Leukemia,Leukemia, Monocytic, Chronic,Monocytic Leukemia, Chronic,Chronic Monocytic Leukemia,Chronic Monocytic Leukemias,Granulocytic Leukemias,Leukemia, Chronic Monocytic,Leukemias, Chronic Monocytic,Leukemias, Granulocytic,Leukemias, Myelocytic,Leukemias, Myelogenous,Leukemias, Myeloid,Monocytic Leukemias, Chronic,Myelocytic Leukemias,Myelogenous Leukemias,Myeloid Leukemias
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D005260 Female Females
D006410 Hematopoiesis The development and formation of various types of BLOOD CELLS. Hematopoiesis can take place in the BONE MARROW (medullary) or outside the bone marrow (HEMATOPOIESIS, EXTRAMEDULLARY). Hematopoiesis, Medullary,Haematopoiesis,Medullary Hematopoiesis
D006412 Hematopoietic Stem Cells Progenitor cells from which all blood cells derived. They are found primarily in the bone marrow and also in small numbers in the peripheral blood. Colony-Forming Units, Hematopoietic,Progenitor Cells, Hematopoietic,Stem Cells, Hematopoietic,Hematopoietic Progenitor Cells,Cell, Hematopoietic Progenitor,Cell, Hematopoietic Stem,Cells, Hematopoietic Progenitor,Cells, Hematopoietic Stem,Colony Forming Units, Hematopoietic,Colony-Forming Unit, Hematopoietic,Hematopoietic Colony-Forming Unit,Hematopoietic Colony-Forming Units,Hematopoietic Progenitor Cell,Hematopoietic Stem Cell,Progenitor Cell, Hematopoietic,Stem Cell, Hematopoietic,Unit, Hematopoietic Colony-Forming,Units, Hematopoietic Colony-Forming
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

B Löwenberg, and W L van Putten, and A Ferrant, and G Ossenkoppele, and E Vellenga, and L F Verdonck, and A Gratwohl, and M A Boogaerts
January 2002, Annals of hematology,
B Löwenberg, and W L van Putten, and A Ferrant, and G Ossenkoppele, and E Vellenga, and L F Verdonck, and A Gratwohl, and M A Boogaerts
May 2001, Annals of hematology,
B Löwenberg, and W L van Putten, and A Ferrant, and G Ossenkoppele, and E Vellenga, and L F Verdonck, and A Gratwohl, and M A Boogaerts
May 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
B Löwenberg, and W L van Putten, and A Ferrant, and G Ossenkoppele, and E Vellenga, and L F Verdonck, and A Gratwohl, and M A Boogaerts
December 1996, Bone marrow transplantation,
B Löwenberg, and W L van Putten, and A Ferrant, and G Ossenkoppele, and E Vellenga, and L F Verdonck, and A Gratwohl, and M A Boogaerts
January 1995, Journal of clinical apheresis,
B Löwenberg, and W L van Putten, and A Ferrant, and G Ossenkoppele, and E Vellenga, and L F Verdonck, and A Gratwohl, and M A Boogaerts
February 1998, Annals of oncology : official journal of the European Society for Medical Oncology,
B Löwenberg, and W L van Putten, and A Ferrant, and G Ossenkoppele, and E Vellenga, and L F Verdonck, and A Gratwohl, and M A Boogaerts
January 1991, Henry Ford Hospital medical journal,
B Löwenberg, and W L van Putten, and A Ferrant, and G Ossenkoppele, and E Vellenga, and L F Verdonck, and A Gratwohl, and M A Boogaerts
March 2004, Bone marrow transplantation,
B Löwenberg, and W L van Putten, and A Ferrant, and G Ossenkoppele, and E Vellenga, and L F Verdonck, and A Gratwohl, and M A Boogaerts
January 1996, Stem cells (Dayton, Ohio),
B Löwenberg, and W L van Putten, and A Ferrant, and G Ossenkoppele, and E Vellenga, and L F Verdonck, and A Gratwohl, and M A Boogaerts
June 2000, Bone marrow transplantation,
Copied contents to your clipboard!